Search Results

Filter
  • 1-10 of  35 results for ""Oxidopamine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Grafts Derived from an α-Synuclein Triplication Patient Mediate Functional Recovery but Develop Disease-Associated Pathology in the 6-OHDA Model of Parkinson's Disease.

  • Authors : Shrigley S; Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund University, Lund, Sweden.; Lund Stem Cell Center, Lund University, Lund, Sweden.

Subjects: Induced Pluripotent Stem Cells* ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/therapy ; Synucleinopathies*

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2021; Vol. 11 (2), pp. 515-528.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

The beneficial effect of vanillin on 6-hydroxydopamine rat model of Parkinson's disease.

  • Authors : Abuthawabeh R; Department of Applied Pharmaceutical Sciences, Faculty of Pharmacy, Israa University, Amman, Jordan.; Abuirmeileh AN

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/pathology

  • Source: Restorative neurology and neuroscience [Restor Neurol Neurosci] 2020; Vol. 38 (5), pp. 369-373.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9005499 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

(-)-Epigallocatechin-3-Gallate protects SH-SY5Y cells against 6-OHDA-induced cell death through STAT3 activation.

  • Authors : Wang L; Department of Neurology and Neurobiology, Key Laboratory on Neurodegenerative Disorders of Ministry of Education, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China. ; Xu S

Subjects: Adrenergic Agents/Adrenergic Agents/Adrenergic Agents/*pharmacology ; Catechin/Catechin/Catechin/*analogs & derivatives ; Neuroprotective Agents/Neuroprotective Agents/Neuroprotective Agents/*pharmacology

  • Source: Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2009; Vol. 17 (2), pp. 295-304.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9814863 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Early pubertal female rats are more resistant than males to 6-hydroxydopamine neurotoxicity and behavioural deficits: a possible role for trophic factors.

  • Authors : Pienaar IS; Division of Medical Physiology, University of Stellenbosch, Western Cape, South Africa. ; Schallert T

Subjects: Sex Characteristics*; Mental Disorders/Mental Disorders/Mental Disorders/*chemically induced ; Nerve Growth Factor/Nerve Growth Factor/Nerve Growth Factor/*metabolism

  • Source: Restorative neurology and neuroscience [Restor Neurol Neurosci] 2007; Vol. 25 (5-6), pp. 513-26.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 9005499 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia.

  • Authors : Cirillo R; Institut des Sciences Cognitives Marc Jeannerod (ISCMJ), Unité Mixte de Recherche 5229 du Centre National de la Recherche Scientifique (CNRS), Bron, France.; Universitè de Lyon 1, Lyon, France.

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy ; Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/diagnostic imaging ; Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/etiology

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2024; Vol. 14 (2), pp. 261-267.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia.

  • Authors : Finlay CJ; Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; Jackson MJ

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy ; Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/drug therapy ; Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/etiology

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2024; Vol. 14 (2), pp. 245-259.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Human Embryonic Stem Cell-Derived Dopaminergic Grafts Alleviate L-DOPA Induced Dyskinesia.

  • Authors : Elabi OF; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.; Pass R

Subjects: Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/drug therapy ; Human Embryonic Stem Cells* ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2022; Vol. 12 (6), pp. 1881-1896.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease.

  • Authors : Tseng KY; National Defense Medical Center, Taipei, Taiwan, R.O.C.; Department of Neurological Surgery, Tri-Service General Hospital, Taipei, Taiwan, R.O.C.

Subjects: Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/etiology ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/complications; Animals

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2022; Vol. 12 (5), pp. 1545-1565.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application.

  • Authors : Hiramatsu S; Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.; Regenerative and Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd, Kobe, Japan.

Subjects: Induced Pluripotent Stem Cells*/Induced Pluripotent Stem Cells*/Induced Pluripotent Stem Cells*/metabolism ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/therapy; Animals

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2022; Vol. 12 (3), pp. 871-884.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats.

  • Authors : Renko JM; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Mahato AK

Subjects: Neuroprotective Agents*/Neuroprotective Agents*/Neuroprotective Agents*/pharmacology ; Parkinson Disease*; Animals

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2021; Vol. 11 (3), pp. 1023-1046.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  35 results for ""Oxidopamine""